发明名称 METHOD FOR GENERATING BETA CELLS
摘要 The invention is directed to methods for generating pancreatic progenitor cells, insulin producing cells or endoderm cells using embryonic stem cells and induced pluripotent stem cells. The present invention also relates to an isolated population comprising pancreatic progenitor cells or a insulin-producing cells, compositions and their use in the treatment of diabetes
申请公布号 US2014242038(A1) 申请公布日期 2014.08.28
申请号 US201414158481 申请日期 2014.01.17
申请人 The Trustees of Columbia University in the City of New York 发明人 HUA Haiqing;EGLI Dieter;LEIBEL Rudolph L.;SHANG Linshan
分类号 C12N5/071 主分类号 C12N5/071
代理机构 代理人
主权项 1. A method for generating a beta cell from a stem cell or an induced pluripotent stem cell, the method comprising: (a) contacting the cells with a first culture medium, wherein the first culture medium is an RPMI medium comprising 1× Pen-Strep and 1× Glutamax and wherein the first culture medium further comprises Activin A, Wnt3A and Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, (b) contacting the cells with a second culture medium, wherein the second culture medium is an RPMI medium comprising 1× Pen-Strep and 1× Glutamax and wherein the second culture medium further comprises Activin A protein and FBS in RPMI medium, (c) contacting the cells with a third culture medium, wherein the third culture medium is an RPMI medium comprising 1× Pen-Strep and 1× Glutamax and wherein the third culture medium further comprises containing human FGF10 protein, KAAD-cyclopamine and FBS in RPMI medium, (d) contacting the cells with a fourth culture medium, wherein the fourth culture medium is an DMEM high glucose medium comprising 1× Pen-Strep and 1× Glutamax and wherein the fourth culture medium further comprises FGF 10, KAAD-cyclopamine, retinoic acid, LDN-193189 and 1×B27, (e) contacting the cells with a fifth culture medium, wherein the fifth culture medium is a CMRL medium comprising 1× Pen-Strep and 1× Glutamax and wherein the fourth culture medium further comprises exedin-4, SB431542 and 1×B27, and (f) contacting the cells with a sixth culture medium, wherein the sixth culture medium is a CMRL medium comprising 1× Pen-Strep and 1× Glutamax and wherein the sixth culture medium further comprises 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetic acid and 1×B27.
地址 New York NY US